MedPath

RELENZA 5 mg/dosis POLVO PARA INHALACIÓN (UNIDOSIS)

RELENZA 5 mg/dosis POLVO PARA INHALACIÓN (UNIDOSIS)

Commercialized
Register Number

62712

Prescription Type

Medicamento Sujeto A Prescripción Médica

Authorization Date

Jul 31, 1999

Dosage Form

POLVO PARA INHALACIÓN

Route: VÍA INHALATORIA

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number62712
EMA Approved
No

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

ZANAMIVIRActive
Quantity: 5 mg
Name: ZANAMIVIR

ATC CLASSIFICATION (3)

J05A
J05AH
J05AH01

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.